The George Washington University (GW) works with many researchers with current projects either in development, or that have commercial potential. One of the goals of the GW Technology Commercialization Office is to highlight GW's research news so the outside community can learn a little about the tireless work from our GW researchers as well as the robustness of the technology that we have available.


La Jolla Pharmaceutical Company and the George Washington University Announce Exclusive Worldwide License Agreement

December 09, 2014

La Jolla Pharmaceutical Company (Nasdaq: LJPC), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, and GW, today announced that they have entered into an exclusive worldwide license agreement for GW intellectual property rights covering the use of angiotensin II for the therapeutic treatment of patients with hypotension and shock.

Why You Want IP For Your Startup

December 01, 2014

"If you want to build a successful startup, you need intellectual property."

GW Researcher Receives $2 Million NIH New Innovator Award

October 08, 2014

Lijie Grace Zhang is advancing the development of tissue and organ replacements.

Medical Testing on the Go

September 09, 2014

GW researchers have developed a diagnostic device that could make portable health care possible.

Allied Minds plc Announces Completion of its Initial Public Offering and Admission to the London Stock Exchange

July 14, 2014

LuxCath, one of Allied Minds portfolio companies, is based on technology exclusively licensed from the George Washington Univeristy.

Protea Commences Stock Trading

April 14, 2014

Market Watch - The Wall Street Journal

Researchers Showcase Technologies with Commercial Potential

March 30, 2014

GW Today highlighted OTT's 3rd Annual Innovation Competition

University Receives Up to $14.6 Million to Investigate Biological and Chemical Threats

January 28, 2014

The project, led by GW Professor of Chemistry Akos Vertes, is funded by the Defense Advanced Research Projects Agency.
GW Today

Protea Announces Expansion of Patent Portfolio

August 27, 2013

Two New Patents Issued for LAESI(R) Two and Three Dimensional Molecular Imaging